Advancing Vision Designed for Every Eye Helping shape the future of vision care with solutions that support people through every stage of life.†3-8
At CooperVision, we're committed to advancing vision*1 through solutions designed for every eye and every stage of life.2,3 By combining innovation, expertise, and a deep understanding of people's evolving vision needs, we're helping more people around the world enjoy clear,†3-8 comfortable3,9,10 vision today while creating possibilities for tomorrow.
Manufacturing the widest range of soft contact lens prescription options‡11
Available in over 130 countries12
Making billions of contact lenses anually§11
Growing faster than the overall soft contact lens market†1
From our groundbreaking introduction of contact lenses proven to slow the progression of myopia in children◊¶6 age 8-12 at the initiation of treatment; to our DigitalBoost™ technology, developed to address the needs of contact lens wearers who lead digital lifestyles; to our creation of the world’s first full family of 1-day silicone hydrogel contact lenses, CooperVision is advancing the range of what contact lenses can do—and bringing ocular advantages to contact lens wearers.
Other important information:
* Combination of 2022 market research based on global volume data and internal estimates
† VA (LogMAR) > 6/6 (20/20) at all visits from dispensing to 6-year visit.
‡ Based on Rx option combinations (sphere, cylinder, axis and add) manufactured, across all soft lenses in sphere, toric and multifocal (including made to order), in silicone hydrogel and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic and photochromatic contact lenses not included. Multiple base curve variants not included.
§ Combination of 2013-2018 market research based on global revenue sales and internal estimates.
◊ Compared to a single vision 1 Day lens over a 3 year period.
¶ Product not available in all markets.
References:
1. CVI data on file, 2023.
2. CVI data on file, 2021. Rx coverage database n=101,973 aged 14 to 70 years.
3. CVI data on file, 2026.
4. CVI data on file, 2024.
5. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study with MyDay® multifocal; n=102 habitual MFCL wearers.
6. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567.
7. Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212.
8. CVI data on file, 2018. clariti 1 day satisfaction survey, n=1718. CVI data on file, 2018. 1-week bilateral DW study with c1d toric, n=39. CVI data on file, 2019. Woods J et al. Visual performance with DD SiH CN progressive design MFCL.
9. CVI data on file, 2018.Observational satisfaction survey in France, n=1718.
10. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation.
11. CVI data on file, 2019.
12. CVI data on file, 2020.